Natasha Berness

Natasha Berness founded SoliVana Research Institute on a singular conviction: that the future of human health lies not in treating symptoms, but in understanding and optimizing the autonomic nervous system at scale.

With a background spanning clinical wellness operations, biomarker analytics, and AI systems architecture, Natasha is pioneering a new category of precision recovery — one that treats the nervous system as the master regulator of human performance, longevity, and resilience.

Under her leadership, SoliVana has developed Protocol NSR-2026, the first longitudinal study to integrate real-time AI analysis with continuous HRV monitoring, sensory deprivation therapy, and comprehensive biomarker mapping — producing data sets that are both clinically rigorous and commercially transformative.

Her vision: a world where nervous system optimization is as accessible, measurable, and personalized as bloodwork.